Common Side Effects of Bosulif
Bosulif (bosutinib), used to treat chronic myeloid leukemia (CML), causes gastrointestinal issues in most patients. These include diarrhea (up to 84% of users), nausea (up to 47%), vomiting (up to 37%), and abdominal pain (up to 41%). Fatigue affects about 43%, headache 37%, and rash 38%. Low platelet count (thrombocytopenia, 44%) and low neutrophil count (neutropenia, 25%) are frequent blood-related effects.[1][2]
Serious Side Effects and Warnings
Severe reactions include liver damage (elevated liver enzymes in 30-40%, with rare liver failure), fluid retention (pericardial effusion in 8%, pleural effusion in 10%), and heart problems (QT prolongation, reduced ejection fraction). Anaphylaxis and severe skin reactions like Stevens-Johnson syndrome occur rarely. Bosulif carries black box warnings for liver toxicity, drug-induced liver injury, and QT prolongation.[1][2][3]
Side Effects by Treatment Duration
Early in treatment (first few months), diarrhea and liver enzyme elevations peak. Long-term use (over 2 years) sees ongoing cytopenias (low blood cells) and effusion risks, but many patients tolerate it better after initial months with dose adjustments.[2][4]
Managing Side Effects
Doctors often start at 400 mg daily, reducing to 300 mg or 200 mg for intolerance. Antidiarrheals like loperamide help; monitor liver function monthly initially. Hydration and antiemetics address nausea. Discontinue if severe liver injury or uncontrolled effusion develops.[1][3]
Side Effects in Specific Groups
Elderly patients (over 65) face higher rates of thrombocytopenia (58%) and effusion (23%). Pediatric data is limited; not approved under 18. Pregnancy causes fetal harm—use contraception. No major differences by race or renal impairment, but dose cuts needed for moderate-severe liver issues.[2][3]
How Bosulif Side Effects Compare to Other TKIs
Versus Sprycel (dasatinib), Bosulif has more diarrhea but less pleural effusion. Imatinib causes less severe GI effects but more fluid retention. All share myelosuppression risks.[4]
[1]: Bosulif Prescribing Information (Pfizer)
[2]: Drugs.com - Bosulif Side Effects
[3]: FDA Label for Bosulif
[4]: Medscape - Bosutinib Dosing and Side Effects